155 related articles for article (PubMed ID: 38359358)
1. Evaluation of Continuous Infusion Vancomycin in a Pediatric Hematology/Oncology Population.
King MA; Cross SJ; Morton TH; Hijano DR; Greene WL; Sun Y; Tang L; Pauley JL; Bourque MS; Christensen AM
Pediatr Infect Dis J; 2024 Jun; 43(6):520-524. PubMed ID: 38359358
[TBL] [Abstract][Full Text] [Related]
2. When There Is No Trough: Use and Outcomes of Continuous-Infusion Vancomycin at a Free-Standing Children's Hospital.
Wysocki E; Tansmore J
J Pediatr Pharmacol Ther; 2022; 27(5):452-456. PubMed ID: 35845557
[TBL] [Abstract][Full Text] [Related]
3. Experience with Continuous Infusion Vancomycin Dosing in a Large Pediatric Hospital.
Hurst AL; Baumgartner C; MacBrayne CE; Child J
J Pediatric Infect Dis Soc; 2019 May; 8(2):174-179. PubMed ID: 29718415
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a pediatric continuous-infusion vancomycin therapy guideline.
McKamy S; Chen T; Lee M; Ambrose PJ
Am J Health Syst Pharm; 2012 Dec; 69(23):2066-71. PubMed ID: 23172265
[TBL] [Abstract][Full Text] [Related]
5. Retrospective review of intermittent and continuous infusion vancomycin for methicillin-resistant Staphylococcus aureus bacteremia.
Gilliam D; Acosta D; Carvour ML; Walraven C
Eur J Clin Pharmacol; 2024 Jan; 80(1):75-81. PubMed ID: 37897529
[TBL] [Abstract][Full Text] [Related]
6. Retrospective multicentre matched cohort study comparing safety and efficacy outcomes of intermittent-infusion versus continuous-infusion vancomycin.
Ma NH; Walker SAN; Elligsen M; Kiss A; Palmay L; Ho G; Powis J; Bansal V; Leis JA
J Antimicrob Chemother; 2020 Apr; 75(4):1038-1046. PubMed ID: 31919504
[TBL] [Abstract][Full Text] [Related]
7. Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial.
Gwee A; Cranswick N; McMullan B; Perkins E; Bolisetty S; Gardiner K; Daley A; Ward M; Chiletti R; Donath S; Hunt R; Curtis N
Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30700564
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of vancomycin improved therapeutic levels in term and preterm infants.
Round A; Clifton E; Stachow L; Mittal S; Yadav K; Ashraf H; Sanghera RS; Ng KF
J Perinatol; 2021 Jun; 41(6):1459-1466. PubMed ID: 33469164
[TBL] [Abstract][Full Text] [Related]
9. Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.
Lin H; Yeh DD; Levine AR
Crit Care; 2016 Jul; 20(1):205. PubMed ID: 27363312
[TBL] [Abstract][Full Text] [Related]
10. Continuous intravenous vancomycin in children with normal renal function hospitalized in hematology-oncology: prospective validation of a dosing regimen optimizing steady-state concentration.
Hoegy D; Goutelle S; Garnier N; Rénard C; Faure-Conter C; Bergeron C; Bertrand Y; Bleyzac N
Fundam Clin Pharmacol; 2018 Jun; 32(3):323-329. PubMed ID: 29315849
[TBL] [Abstract][Full Text] [Related]
11. Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible.
Hussain K; Salat MS; Rauf S; Rathi M; Khan M; Naz F; Khan WA; Ikram R; Ambreen G
BMC Pharmacol Toxicol; 2022 Aug; 23(1):64. PubMed ID: 35987842
[TBL] [Abstract][Full Text] [Related]
12. Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis.
Hao JJ; Chen H; Zhou JX
Int J Antimicrob Agents; 2016 Jan; 47(1):28-35. PubMed ID: 26655032
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
Sin JH; Newman K; Elshaboury RH; Yeh DD; de Moya MA; Lin H
J Antimicrob Chemother; 2018 Jan; 73(1):199-203. PubMed ID: 29040561
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Continuous Infusion of Vancomycin in Children: A Systematic Review.
Alonso-Moreno M; Mejías-Trueba M; Herrera-Hidalgo L; Goycochea-Valdivia WA; Gil-Navarro MV
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438962
[TBL] [Abstract][Full Text] [Related]
15. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
Xu G; Chen E; Mao E; Che Z; He J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant
Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ
Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
[No Abstract] [Full Text] [Related]
17. Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.
Gwee A; Cranswick N; Donath SM; Hunt R; Curtis N
BMJ Open; 2018 Nov; 8(11):e022603. PubMed ID: 30391914
[TBL] [Abstract][Full Text] [Related]
18. Intermittent vs. continuous vancomycin infusion for gram-positive infections: A systematic review and meta-analysis.
Chu Y; Luo Y; Quan X; Jiang M; Zhou B
J Infect Public Health; 2020 Apr; 13(4):591-597. PubMed ID: 31530441
[TBL] [Abstract][Full Text] [Related]
19. Continuous Infusion Vancomycin in Pediatric Patients: A Critical Review of the Evidence.
Girand HL
J Pediatr Pharmacol Ther; 2020; 25(3):198-214. PubMed ID: 32265603
[TBL] [Abstract][Full Text] [Related]
20. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.
Wysocki M; Delatour F; Faurisson F; Rauss A; Pean Y; Misset B; Thomas F; Timsit JF; Similowski T; Mentec H; Mier L; Dreyfuss D
Antimicrob Agents Chemother; 2001 Sep; 45(9):2460-7. PubMed ID: 11502515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
